Accessibility statement
Last updated: July 2026
How accessible CardioBridge is, what we have verified, what we have not, and how to tell us when we have got it wrong.
1. Our commitment
CardioBridge is used by clinicians, clinic staff and patients, and a diagnostic service is of no use to someone who cannot operate it. We treat accessibility as part of clinical safety rather than as a presentation concern, and we design for it from the outset: colour is never the only way we signal status, every interface is operable by keyboard, and motion is always optional. This statement applies to the public website at cardiobridge.teqdr.com and to the signed-in CardioBridge application.
2. The standard we work to
We aim to meet the Web Content Accessibility Guidelines (WCAG) 2.1 at Level AA. Our internal design system sets this as a binding requirement for every screen and pattern, and it is checked at code review before any change ships.
3. What we have done
Colour is never the sole carrier of meaning — status and urgency always pair an icon and a text label with the colour. Body and secondary text is held to a minimum contrast ratio of 4.5:1, and reduced-opacity text is reserved for decorative marks that assistive technology already ignores. Every interface is fully keyboard-operable with a visible focus indicator, and scrollable regions such as code and document panes are themselves focusable so keyboard users can reach and scroll them. Animated and diagrammatic figures are exposed to assistive technology as a single image with a plain-English description, because an animation cannot be read by a screen reader. All motion respects the operating system's reduce-motion setting.
4. Known limitations — how conformant we actually are
We describe CardioBridge as PARTIALLY CONFORMANT with WCAG 2.1 AA. We are being deliberately precise here rather than claiming more than we can evidence. No independent accessibility audit has been carried out, and we do not yet run an automated accessibility check on every build, so our conformance is asserted from design review rather than demonstrated by testing. We have not yet completed a full assessment of the signed-in clinical workstation, of issued PDF reports, or of screens supplied by third-party components such as payment forms. Performance scores are sometimes mistaken for accessibility evidence; they are not, and we do not offer them as such. We would rather tell you where we are unverified than imply a level of assurance we have not earned.
5. What we are doing next
We are working towards a continuous automated accessibility check on every build, a full assessment of the signed-in application and of issued reports, and an independent audit. We will update this statement, and the date at the top of it, as each of those completes.
6. Telling us about a problem
If you encounter a barrier anywhere in CardioBridge — on the website, in the application, or in a report you have been sent — please tell us at cardiobridge@teqdr.com. Describe the page or screen and what you were trying to do, and let us know if you need a reply in a particular format. We aim to acknowledge within 5 working days and to tell you what we intend to do about it. If you need information from CardioBridge in an alternative format, ask us at the same address and we will arrange it.
7. If you are not satisfied
If you raise a problem with us and are not happy with our response, you can contact the Equality Advisory and Support Service (EASS), which advises on the Equality Act 2010 in England, Scotland and Wales. Patients and users in other countries we serve retain the equivalent rights available to them locally.
8. About this statement
This statement was prepared on 30 July 2026 based on a self-assessment of CardioBridge against WCAG 2.1 AA. It has not been independently reviewed. We keep it under review alongside our wider compliance documentation and will republish it whenever our position changes.